Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Kina vs Nouri

Kina
Graded #115

Higher grade

vs+15
Nouri
Graded #455

Lower grade

The verdict

Kina takes it — 69.8/100 to 54.8/100.

Kina grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueKina +15
60
45
Dose & formulationKina +24
64
40
Clinical oversightKina +24
88
64
Labs & monitoringKina +11
64
53
FulfillmentNouri +4
83
87
Contract termsKina +6
61
55
Kina · left barNouri · right bar

The numbers

MetricKinaNouri
WeighScore69.8/10054.8/100
GradeCC
Scorecard rank#115#455
Semaglutide$179/mo (starting dose, plus a separate fee, compounded)Not disclosed
Tirzepatide$179/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Kina

Graded #115 · C

Strengths

  • Menopause-specialized care — GLP-1 weight treatment alongside HRT, peptide, and compounded options for menopause symptoms
  • Prescribed and monitored by named board-certified physicians at Arora Health & Aesthetics, with dose adjustments included
  • Verifiable LegitScript certification (seal ID 50917967)
  • GLP-1 from $179/month with $0 membership fees, FSA/HSA eligibility, free shipping, and cancel-anytime
  • Compounded semaglutide and tirzepatide, 100% online with a roughly 2-minute intake

Where it loses points

  • Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Built for women navigating menopause — less tailored if that is not your situation
  • A separate $50 physician consultation fee applies on top of the medication price
  • The compounding pharmacy partner is not named, and the full list of served states is not published
Nouri

Graded #455 · C

Strengths

  • Named clinical MSO partner (Wasef Health, PC; Michael Wasef, MD) with public contact email
  • Named 503A compounding pharmacy partner (Jungle Jim's Pharmacy, Fairfield OH) with full address
  • Available in all 50 states per the FAQ
  • Flat per-dose pricing within each tier — no dose-escalation surcharge
  • Nutrition and movement coaching included in the medication price

Where it loses points

  • Compounded medications only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
  • Operating entity name not disclosed in the Terms of Service
  • Terms 'where we operate' language is slightly weaker than the FAQ's all-50-states claim
  • Video visit required in some states, but those states aren't listed
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard